Pacira BioSciences, Inc. (PCRX) Institutional Ownership

Ownership Summary

Pacira BioSciences, Inc. (NASDAQ:PCRX) showed up in the 13F filings of 253 institutional investors as of December 2025.

• Collectively, these holders controlled 106.1% of Pacira BioSciences's outstanding shares in December 2025, down from 109.4% in September 2025.
• Their total shares held in PCRX decreased -0.78% from the prior quarter, while the number of investors in Pacira BioSciences increased 9.05% year over year.
• During the quarter, 134 of these 253 funds increased positions in PCRX, 91 reduced exposure, and 28 held steady.
• The aggregate institutional position in Pacira BioSciences amounted to 47.19Mn shares as of December 2025, down by 371.15K shares quarter on quarter, and down 4.48Mn shares year over year.
• As of December 31, 2025, BlackRock, Inc. held the largest stake in Pacira BioSciences with 6.74Mn shares, accounting for 15.15% of total shares outstanding.
• Leading buyers of Pacira BioSciences shares for the quarter ending December 2025 were VANGUARD PORTFOLIO MANAGEMENT LLC (2.5Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.78Mn), VANGUARD FIDUCIARY TRUST CO (267.79K), Morgan Stanley (199.95K), LSV ASSET MANAGEMENT (197.3K).
• The biggest sellers of Pacira BioSciences for the quarter ending December 2025 included Goldman Sachs Group Inc (1.03Mn), BALYASNY ASSET MANAGEMENT L.P. (839.56K), AMERICAN CENTURY COMPANIES INC (498.48K), J. Goldman & Co LP (339.48K), BlackRock, Inc. (328.94K).
• Per Business Quant data, the top 10 holders of Pacira BioSciences for the quarter ending December 2025 are BlackRock, Inc. (6.74Mn), Doma Perpetual Capital Management LLC (2.78Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.5Mn), DIMENSIONAL FUND ADVISORS LP (2.06Mn), D. E. Shaw & Co., Inc. (1.98Mn), State Street Corp (1.92Mn), RENAISSANCE TECHNOLOGIES LLC (1.83Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.78Mn), Goldman Sachs Group Inc (1.57Mn), Morgan Stanley (1.39Mn).